Immune reactions induced by interleukin-2 transfected colorectal cancer cells in vitro: predominant induction of lymphokine-activated killer cells

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of molecular medicine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF00202071PMID 8834769
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• T‐cell‐receptor engagement and tumor ICAM‐1 up‐regulation are required to by‐pass low susceptibility of melanoma cells to autologous CTL‐mediated lysis

  2009cited by this paper
• Effects of cytokines on in vitro growth of tumor-infiltrating lymphocytes obtained from human primary and metastatic liver tumors

  2005cited by this paper
• Induction of tumor-specific cytotoxic T lymphocytes and natural killer cells by tumor cells transfected with the interleukin-2 gene

  2005cited by this paper
• Biologic therapy of cancer, 2nd edition, V.T. DeVita, S. Heuman, S.A. Rosenberg (Eds.). Lippincott, New York (1995), ISBN: 0-397-51416-6

  1996cited by this paper
• Development of immunogenic colorectal cancer cell lines for vaccination: expression of CD80 (B7.1) is not sufficient to restore impaired primary T cell activation in vitro.

  1995cited by this paper
• Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition.

  1995cited by this paper
• IL-2 gene-transduced human HLA-A2 melanoma cells can generate a specific antitumor cytotoxic T-lymphocyte response.

  1995cited by this paper
• Elicitation of a systemic and protective anti-melanoma immune response by an IL-2-based vaccine. Assessment of critical cellular and molecular parameters.

  1995cited by this paper
• Interleukin-Gene-Transduced Human Melanoma Cells Efficiently Stimulate MHC-Unrestricted and MHC-Restricted Autologous Lymphocytes

  1994cited by this paper
• Experimental and Clinical Studies of Cytokine Gene-Modified Tumor Cells

  1994cited by this paper
• The immunobiological effects of interleukin-2 in vivo

  1994cited by this paper
• In vitro modulation of the invasive and metastatic potentials of human renal cell carcinoma by interleukin‐2 and/or interferon‐alpha gene transfer

  1994cited by this paper
• Interleukin-2 and lymphokine activated killer (LAK) cells

  1993cited by this paper
• Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes: modulation of recognition through retroviral transduction of tumor cells with interleukin 2 complementary DNA and exogenous alpha interferon treatment.

  1993cited by this paper
• Analysis of cytolytic effector cell response in vitro against autologous human tumor cells genetically altered to synthesize interleukin-2.

  1993cited by this paper
• Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines.

  1993cited by this paper
• Natural killer cells and the MHC class I pathway of peptide presentation.

  1993cited by this paper
• Expansion of tumor-infiltrating lymphocytes from human tumors using the T-cell growth factors interleukin-2 and interleukin-4.

  1993cited by this paper
• Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells.

  1992cited by this paper
• Soluble HLA-A2.1 restricted peptides that are recognized by influenza virus specific cytotoxic T lymphocytes.

  1991cited by this paper
• Human melanoma cells with high susceptibility to cell‐mediated lysis can be identified on the basis of icam‐1 phenotype, vla profile and invasive ability

  1990cited by this paper
• Tumor-infiltrating lymphocytes from human colon carcinomas

  1990cited by this paper
• Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response.

  1990cited by this paper
• Intraperitoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity.

  1990cited by this paper
• Tumor-infiltrating lymphocytes from human colon carcinomas. Functional and phenotypic characteristics after long-term culture in recombinant interleukin 2.

  1990cited by this paper
• Regulated expression of foreign genes in mammalian cells under the control of coliphage T3 RNA polymerase and lac repressor.

  1989cited by this paper
• Production of stable cytolytic T‐cell clones directed against autologous human melanoma

  1987cited by this paper
• An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein.

  1984cited by this paper

• Gene Therapy Strategies for Colorectal Cancer

  2002cites this paper
• The differential effect of stress on natural killer T (NKT) and NK cell function

  2000cites this paper
• Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial

  1999cites this paper
• Analysis of the T Cell Receptor Variability of Tumor-Infiltrating Lymphocytes in Colorectal Carcinomas

  1998cites this paper
• Can immunotherapy by gene transfer tip the balance against colorectal cancer?

  1998cites this paper
• Induction of antigen-specific T cells by allogeneic CD80 transfected human carcinoma cells.

  1998cites this paper